Regeneron Pharmaceuticals

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$475.76-$1,019.98
Market Cap
$59.7B
Shares Short
2M

Financials

See more
Revenue (12 Mos)
$14.2B
Revenue Growth (YoY)
3.6%
Gross Profit (12 Mos)
$6.7B
Diluted EPS
$39.70

News

See more

Yahoo Finance • 6 hours ago

Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab

Yahoo Finance • 19 hours ago

Regeneron gets FDA nod for squamous cell carcinoma therapy

Yahoo Finance • 20 hours ago

Libtayo® (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation

Yahoo Finance • yesterday

Cutaneous Squamous Cell Carcinoma Market Forecast Report 2025-2035, with Focus on Regeneron Pharmaceuticals, Sanofi, Merck & Co., Checkpoint Therapeutics, Incyte, and Sirnaomics

About

CEO
Dr. Leonard S. Schleifer M.D., Ph.D.
CFO
Mr. Christopher R. Fenimore CPA
Address
777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
15,182